25,000,000 Eyes Will Be Tested for Glaucoma World Wide With DIATON Tonometer Starting On World Glauc
25,000,000 Eyes Will Be Tested for Glaucoma World Wide With DIATON Tonometer Starting On World Glaucoma Day
Since IntraOcular(IOP) or Eye Pressure is one of the major risk factors of Glaucoma, early detection is the key to preventing blindness. BiCOM Inc with its unique, Non-Corneal and Over-the-Eyelid Tonometer DIATON is challenging the "Sneak Thief of Sight" through awareness and screening events on World Glaucoma Day. Handheld Diaton Tonometer is ideal for mass screening because it is quick, painless and non-invasive glaucoma IOP eye test.
Glaucoma accounts for over 7 million visits to physicians each year. Since IntraOcular Pressure (IOP) or (Eye Pressure) is one of the major risk factors for developing Glaucoma, early detection is the key to preventing blindness.
BiCOM is advising and guiding all of its tonometer Diaton http://www.TonometerDiaton.com users and distributors located in over 60 countries in North and South America, Europe, Asia and Middle East to participate in the World Glaucoma Day and Week on March 12th through Screening and Awareness campaigns.
World Glaucoma Day and Week http://www.wgday.org is only a pivot point for greater awareness and should be continued throughout the year.
BiCOM Inc. estimates that, in 2010 Diaton Tonometers and its users will screen 25 million eyes worldwide.
Throughout the year BiCOM Inc., holds various free screening events in conjunction with Department of Transportation (DOT), Lions Clubs, Health Action Groups, Corporate health fairs, as well as independent screening events at churches, synagogues and shelters.
Handheld Diaton Tonometer is ideal for mass screening because it is quick, painless and non-invasive Tonometry procedure. The measurement is taken Over-the-Eyelid with no corneal contact, requiring no anesthesia and having no risk of infecting the eye.
For the 3rd consecutive World Glaucoma Day, BiCOM Inc will be holding various screening awareness events throughout New York as well as internationally throughout its network of Diaton Tonometer distributors.
Diaton Tonometer is intended for use by Inpatient & Outpatient Clinics such as Hospitals, Emergency Rooms, Nursing & Elderly Homes, General & Specialty Practitioners as well as Ophthalmologists and Optometrists.
60 million Americans are at RISK for developing Glaucoma. Glaucoma is usually symptomless and vision loss is irreversible. Often people experience loss of peripheral (side) vision first and compensate for this loss by turning their head.
Prevent Blindness America Survey estimates that over 4 million Americans have glaucoma but only half of those know they have it. It is important to get the eye pressure (IOP) checked at least once a year. Glaucoma is 6 to 8 times more common in African-Americans than Caucasians. With early detection, medications and surgeries can be used to prevent further vision loss.
Roman Iospa, CEO of BiCOM Inc., stated, - "I would like to reiterate that early detection is important and everyone should get screened, but early detection is only a first step. My company (BICOM Inc.,) is consistently investing into research and development of new technologies and currently sponsors a number of research projects in the field of blindness prevention due to glaucoma and a number of other eye diseases."
Since IntraOcular(IOP) or Eye Pressure is one of the major risk factors of Glaucoma, early detection is the key to preventing blindness. BiCOM Inc with its unique, Non-Corneal and Over-the-Eyelid Tonometer DIATON is challenging the "Sneak Thief of Sight" through awareness and screening events on World Glaucoma Day. Handheld Diaton Tonometer is ideal for mass screening because it is quick, painless and non-invasive glaucoma IOP eye test.
Glaucoma accounts for over 7 million visits to physicians each year. Since IntraOcular Pressure (IOP) or (Eye Pressure) is one of the major risk factors for developing Glaucoma, early detection is the key to preventing blindness.
BiCOM is advising and guiding all of its tonometer Diaton http://www.TonometerDiaton.com users and distributors located in over 60 countries in North and South America, Europe, Asia and Middle East to participate in the World Glaucoma Day and Week on March 12th through Screening and Awareness campaigns.
World Glaucoma Day and Week http://www.wgday.org is only a pivot point for greater awareness and should be continued throughout the year.
BiCOM Inc. estimates that, in 2010 Diaton Tonometers and its users will screen 25 million eyes worldwide.
Throughout the year BiCOM Inc., holds various free screening events in conjunction with Department of Transportation (DOT), Lions Clubs, Health Action Groups, Corporate health fairs, as well as independent screening events at churches, synagogues and shelters.
Handheld Diaton Tonometer is ideal for mass screening because it is quick, painless and non-invasive Tonometry procedure. The measurement is taken Over-the-Eyelid with no corneal contact, requiring no anesthesia and having no risk of infecting the eye.
For the 3rd consecutive World Glaucoma Day, BiCOM Inc will be holding various screening awareness events throughout New York as well as internationally throughout its network of Diaton Tonometer distributors.
Diaton Tonometer is intended for use by Inpatient & Outpatient Clinics such as Hospitals, Emergency Rooms, Nursing & Elderly Homes, General & Specialty Practitioners as well as Ophthalmologists and Optometrists.
60 million Americans are at RISK for developing Glaucoma. Glaucoma is usually symptomless and vision loss is irreversible. Often people experience loss of peripheral (side) vision first and compensate for this loss by turning their head.
Prevent Blindness America Survey estimates that over 4 million Americans have glaucoma but only half of those know they have it. It is important to get the eye pressure (IOP) checked at least once a year. Glaucoma is 6 to 8 times more common in African-Americans than Caucasians. With early detection, medications and surgeries can be used to prevent further vision loss.
Roman Iospa, CEO of BiCOM Inc., stated, - "I would like to reiterate that early detection is important and everyone should get screened, but early detection is only a first step. My company (BICOM Inc.,) is consistently investing into research and development of new technologies and currently sponsors a number of research projects in the field of blindness prevention due to glaucoma and a number of other eye diseases."